arrow
H

Hey Min Lee

The University of Texas MD Anderson Cancer Center
H指数:8
被引数:358

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1/2 trial of encorafenib, cetuximab, and nivolumab in microsatellite stable BRAFV600E metastatic colorectal cancer

Ⅰ/Ⅱ期临床试验:encorafenib、cetuximab和nivolumab在微卫星稳定型BRAFV600E转移性结直肠癌中的应用

2025-08-280
OAAI
Epigenome Reprogramming Through H3K27 and H3K4 Trimethylation as a Resistance Mechanism to DNA Methylation Inhibition in BRAFV600E-Mutated Colorectal Cancer
2024-09-130
PRE
Defining the KRAS- and ERK-dependent transcriptome in KRAS-mutant cancers
Science
IF45.8
2024-01-010
OA
Antitumor Efficacy of Dual Blockade with Encorafenib plus Cetuximab in Combination with Chemotherapy in Human BRAFV6°°E-Mutant Colorectal Cancer
2023-04-116
OAAI
ARID1A Mutation May Define an Immunologically Active Subgroup in Patients with Microsatellite Stable Colorectal Cancer

ARID1A突变可能定义微卫星稳定的结直肠癌患者的免疫活性亚组

2021-01-0724
OA